Journal of Genetic Engineering and Biotechnology

Table 1 Mean ± SD of different parameters in the studied groups

From: The potential role of miR-27a and miR-320a in metabolic syndrome in obese Egyptian females

Parameters	*Groups*		*p-value*
Parameters	Group 1 (control n = 23)	Group 2 (metabolic syndrome n = 50)	*p-value*
Body mass index (BMI), kg/m²	23.6073 ± 2.874	33.59 ± 6.7092***	P = 0.0001
Waist circumference (cm)	79.3043 ± 5.506	112.08 ± 11.11**	P = 0.0041
Fasting blood glucose, mg/dl	80.21 ± 12.44	193.6 ± 50.2***	P = 0.0001
Serum insulin, μ IU/ml	11.8457 ± 3	16.652 ± 3.9*	P = 0.013
Insulin resistance, HOMA-IR	2.3207 ± 0.9	8.25 ± 2***	P = 0.0001
Total cholesterol, mg/dl	159.4783 ± 26.1688	197 ± 44.49811***	P = 0.0001
Triglycerides, mg/dl	60.3043 ± 22.85216	177.32 ± 30.21***	P = 0.0001
LDL-cholesterol, mg/dl	79.5217 ± 25.41385	122.436 ± 22.12279***	P = 0.0001
VLDL-cholesterol, mg/dl	12.0609 ± 4.57043	35.464 ± 13.78567***	P = 0.0001
HDL-cholesterol, mg/dl	79.5217 ± 18.76377	41.48 ± 9.37633***	P = 0.0001

*Means significant with P < 0.05. **Means significant with P < 0.005. ***Means significant with P < 0.0001

Back to article page